Medication info
CRB Tablet 10/160mg

CRB Tablet 10/160mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletAmlodipine Besylate›13.87mg / 1 tablet
Manufacturer / importer
Kujoo Pharmaceutical Co., Ltd.
Appearance
Bright yellow oval film-coated tablet
Packaging
28 tablets/box [14 tablets/PTP*2]
Approval status
Active

MFDS item code 201308558 · Approved 2013.07.31 · Insurance code 669804260

Summary

Main use
Treatment of essential hypertension not adequately controlled with amlodipine or valsartan monotherapy
Who takes it
Adults · Children
Adult dose
The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary for patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.
Child dose
The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Ingredients

Manufacturer
Kujoo Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not adequately controlled with amlodipine or valsartan monotherapy

  • Essential hypertension
View approved original text

This medication is used in patients with essential hypertension whose blood pressure is not sufficiently controlled with monotherapy of Amlodipine or Valsartan.

How to take

Adult dose

The recommended dose of this medicine is 1 tablet once daily, taken with water regardless of meals. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or valsartan). However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to this medicine may be considered as follows. ㆍ5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. ㆍ5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. ㆍ10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients taking valsartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. Patients with renal impairment: No dosage adjustment is necessary for patients with mild or moderate renal impairment (creatinine clearance 10mL/min or greater); however, this medicine should not be administered to patients with severe renal impairment (creatinine clearance less than 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. This medicine should not be administered to patients with severe hepatic impairment, biliary cirrhosis, or biliary obstruction/cholestasis. Elderly patients aged 65 years or older: Caution should be exercised when increasing the dose.

Child dose

The safety and efficacy of this medicine have not been established in pediatric patients under 18 years of age; therefore, its use is not recommended.

Precautions

This medication may cause serious harm or death to the fetus and newborn if taken during the second and third trimesters of pregnancy, therefore it should be discontinued immediately upon confirmation of pregnancy. It should not be used in patients with allergies to the active ingredient or similar class of medications, in pregnant or breastfeeding women, patients with severe kidney or liver disease, and patients with certain heart diseases. Patients with insufficient sodium or fluid in the body, high blood potassium levels, issues with renal blood vessels, patients who have recently received a kidney transplant, patients with a history of vascular edema, and patients after heart failure or myocardial infarction should be particularly cautious with this medication and require close monitoring by a physician. While taking this medication, side effects such as headache, dizziness, swelling, lowered blood pressure, dyspepsia, and skin rashes may occur. If any abnormal symptoms arise, immediate consultation with healthcare personnel is necessary. Beware that dizziness and fatigue may occur during driving or operating machinery, and if blood pressure falls sharply, it may be necessary to lay the patient down and administer fluids as needed as an emergency measure. This medication may interact with other antihypertensive medications, potassium supplements, certain diuretics, and some anti-inflammatory drugs; therefore, it is essential to inform your doctor or pharmacist if taking other medications. Pregnant women or those planning to become pregnant should not use this medication, and its use is not recommended for breastfeeding women. Safety and efficacy in children have not been adequately established, so it is preferable not to use it in this population. For the elderly, standard doses similar to adults are recommended, but administration should be done with caution considering individual conditions. In case of overdose, severe hypotension, dizziness, tachycardia, etc., may occur, hence it is crucial to adhere to the prescribed dosage and visit a medical institution immediately if any abnormal symptoms arise.

Side effects

Pharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, dizziness, drowsiness, positional vertigo, paresthesia, lightheadedness, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, dry mouth, rash, erythema, sweating, rash, itching, joint swelling, low back pain, arthritis, muscle cramps, lethargy, polyuria, nocturia, erectile dysfunction, edema, peripheral edema, facial edema, peripheral edema, fatigue, flushing, asthenia, facial flushing, decreased hemoglobin, decreased hematocrit, neutropenia, thrombocytopenia, hypersensitivity including serum sickness, increased serum potassium, vasculitis, elevated liver function tests, angioedema, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, reduced libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, mood changes, tremor, sensory impairment, taste disturbance, peripheral neuropathy, hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, photosensitivity reaction, angioedema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disorders, nocturnal enuresis, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, increased liver enzymes, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, neuroexcitation, Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly sealed container to protect it from air and moisture. It is important to maintain storage temperatures between 1 to 30 degrees Celsius. This helps to preserve the drug's efficacy and safety over time.

Appearance and packaging

Appearance

Bright yellow oval film-coated tablet

Package unit

28 tablets/box [14 tablets/PTP*2]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.